Publikationen 2016 (Auswahl)

Debruyne FM, Behre HM, Roehrborn CG, Maggi M, Wu FC, Schröder FH, Jones TH, Porst H, Hackett G, Wheaton OA, Martin-Morales A, Meuleman E, Cunningham GR, Divan HA, Rosen RC; RHYME Investigators. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: Prostate health outcomes in the Registry of Hypogonadism in Men (RHYME). BJU Int. 2016 Jul 13. [Epub ahead of print]  PMID: 27409523

Simoni M, Santi D, Negri L, Hoffmann I, Muratori M, Baldi E, Cambi M, Marcou M, Greither T, Baraldi E, Tagliavini S, Carra D, Lombardo F, Gandini L, Pallotti F, Krausz C, Rastrelli G, Ferlin A, Menegazzo M, Pignatti E, Linari F, Marino M, Benaglia R, Levi-Setti PE, Behre HM. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. Hum Reprod. 2016 Jun 20. [Epub ahead of print] PMID: 27329968

Brock G, Heiselman D, Maggi M, Kim SW, Rodríguez Vallejo JM, Behre HM, McGettigan J, Dowsett SA, Hayes RP, Knorr J, Ni X, Kinchen K. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study. J Urol. 2016 Mar;195(3):699-705. PMID: 26498057


Publikationen 2015 (Auswahl)

Behre H.M., Howles C.M., Longobardi S; PERSIST Study Investigators. Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation. Reprod Biomed Online. 2015 Jun 15. pii: S1472-6483(15)00261-8. 26194884

Brock G., Heiselman D., Maggi M., Kim S.W., Rodríguez Vallejo J.M., Behre H.M., McGettigan J., Dowsett S.A., Hayes R.P., Knorr J., Ni X., Kinchen K. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study. J Urol. 2015 Oct 20. pii: S0022-5347(15)05023-5. 26498057

Zoch A., Mayerl S., Schulz A., Greither T., Frappart L., Rübsam J., Heuer H., Giovannini M., Morrison H. Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation. PLoS One. 2015 Aug 10;10(8):e0129151. 26258444

Kraus M., Greither T.Wenzel C., Bräuer-Hartmann D., Wabitsch M., Behre H.M. Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgen-regulated microRNA miR-375. Mol Cell Endocrinol. 2015;414:177-85. 26219823

Bache M., Rot S., Keßler J., Güttler A., Wichmann H., Greither T., Wach S., Taubert H., Söling A., Bilkenroth U., Kappler M., Vordermark D. mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma. Oncol Rep. 2015 Jun;33(6):3155-61. 25963717

Wach S., Al-Janabi O., Weigelt K., Fischer K., Greither T.Marcou M., Theil G., Nolte E., Holzhausen H.J., Stöhr R., Huppert V., Hartmann A., Fornara P., Wullich B., Taubert H. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer. Int J Cancer. 2015;137(6):1406-16. 25754273

Behre H.M., Bergmann M., Simoni M., Tüttelmann F. Primary Testicular Failure. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000-2015 Aug 30.   25905302

Publikationen 2014 (Auswahl)

Pexman-Fieth C., Behre H.M., Morales A., Kan-Dobrosky N., Miller M.G.  A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male. 2014;17(1):1-11. 24274081

Kehlen A., Greither T., Wach S., Nolte E., Kappler M., Bache M., Holzhausen H.J., Lautenschläger C., Göbel S., Würl P., Immel U.D., Agaimy A., Wullich B., Taubert H. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients. Int J Cancer. 2014;135(9):2096-106. 24676787